Comparative Pharmacology
Head-to-head clinical analysis: PLASMA LYTE 56 IN PLASTIC CONTAINER versus PLASMA LYTE R IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: PLASMA LYTE 56 IN PLASTIC CONTAINER versus PLASMA LYTE R IN PLASTIC CONTAINER.
PLASMA-LYTE 56 IN PLASTIC CONTAINER vs PLASMA-LYTE R IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
PLASMA-LYTE 56 is an isotonic crystalloid solution that provides electrolytes and water to maintain or restore intravascular volume and electrolyte balance. It expands extracellular fluid volume and improves circulation by increasing plasma volume. The solution's electrolyte composition mimics plasma, helping to correct electrolyte deficits and acid-base disturbances.
Plasma-Lyte R provides electrolytes and water to maintain or restore fluid balance, with bicarbonate precursors (acetate, gluconate) to buffer metabolic acidosis.
Intravenous infusion; dose depends on fluid and electrolyte needs; typical adult rate: 100-200 mL/hour.
Intravenous infusion at a rate of 25-50 mL/kg body weight per 24 hours, adjusted for fluid and electrolyte needs. Typical adult maintenance dose: 1-2 L/day.
None Documented
None Documented
Not applicable as a fixed value; infused electrolytes distribute and are eliminated according to individual ion kinetics (e.g., sodium t½ ~30 min, chloride t½ ~1–2 h) with rapid redistribution.
Not applicable (Plasma-Lyte R components are endogenous electrolytes and water; administered crystalloid redistributes rapidly; half-life of approximately 20-30 minutes for volume expansion due to renal excretion and redistribution into interstitial space)
Primarily renal; >90% of infused electrolytes are excreted unchanged in urine; fecal elimination negligible (<5%).
Renal: >90% (electrolytes and water); Biliary/fecal: negligible (<5%)
Category C
Category C
Intravenous Electrolyte Solution
Intravenous Electrolyte Solution